Motion Sensor Biofeedback Improves Low Back Pain

by / Thursday, 28 January 2016 /

Changing a person’s posture and movement using motion-sensor biofeedback reduces pain and reduces limitations in activity in patients with low back pain (LBP) compared with guidelines-based management, Danish researchers have found in a comparative effectiveness study.

Relative improvements on these outcomes in the movement biofeedback group compared with the guidelines-based group ranged from 15% to 27% at 3 months to 35% to 47% at 12 months, which were all above the threshold for clinically important difference.

Treatment effects were “moderate to large” at the end of the 10-week treatment period, and they “remained or increased at the 12 month follow-up, “in a health condition where interventions typically show small to moderate effects that are not sustained 12 months later,” they add.

Integrity Life Sciences delivers a multitude of orthotic treatment options to address one of the most costly systemic ailments in the world, chronic low back and neck pain. Our advanced solution begins with the Integrity Spinal Care System (ISCS). Our ISCS non-surgical spinal decompression therapy systems are engineered to provide pain relief for compressive and degenerative conditions of the spine. Specifically, conditions that may be treated include: neck pain and back pain associated with herniated discs, protruding discs, degenerative disc disease, posterior facet syndrome, and sciatica. It achieves these effects through decompression of intervertebral discs, that is, unloading due to distraction and positioning.

As a compliment to the ISCS, Integrity offers the very effective Integrity Gel Support Brace. Our advanced lumbar support brace is a fitting compliment to non-surgical spinal decompression therapy and was designed as an adjunct therapy for those suffering from back pain due to disc related conditions. The Integrity Gel Support Brace may be used with or without Integrity’s non-surgical spinal decompression systems and is an excellent treatment option for the patient to use at home.

In addition, Integrity Life Sciences has been exclusively granted the use of all of the technology, products, US Patent and Trademark Office’s assignments, logos and other forms of intellectual property that were created by Axiom Worldwide, Inc. The agreement specifically includes the flagship product DRX 9000, its family of products, and all of its derivatives such as the DRX9000C. Integrity offers support for these products, which includes: sales, maintenance services, and repairs.

Read more: www.IntegrityLifeSciences.com or www.AxiomWorldwide.com

Elements as Published in MedPage Today

TOP